Tokyo, July 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058425) titled 'Study on the failure to achieve the target LDL cholesterol level in patients with dyslipidaemia' on July 10.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - Dyslipidaemia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The target LDL-C non-achievement rate and its actual situation will be clarified for each risk category defined based on JAS GL2022.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 18 years or older with dyslipidaemia who have LDL-C test results between 1 August 2022 and 31 March 2024.
Key exclusion criteria - N/A
Target Size - 200000
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 03 Month 26 Day
Date of IRB - 2025 Year 04 Month 16 Day
Anticipated trial start date - 2025 Year 04 Month 16 Day
Last follow-up date - 2025 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066250
Disclaimer: Curated by HT Syndication.